Canaccord Genuity Upgrades RTI Biologics (RTIX) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/9/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- Atlassian results seen as 'game changer' for AI kills software worries
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Craig-Hallum Upgrades RTI Biologics (RTIX) to Buy
April 25, 2014 8:12 AM EDTCraig-Hallum upgraded RTI Biologics (NASDAQ: RTIX) from Hold to Buy with a price target of $5.00.
For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.
Shares of RTI Biologics closed at $3.93 yesterday.
... MoreRTI Biologics, Inc. (RTIX) Tops Q1 EPS by 2c; Boosts Outlook
April 24, 2014 8:12 AM EDTRTI Biologics, Inc. (NASDAQ: RTIX) reported Q1 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $60.7 million versus the consensus estimate of $55.4 million.
RTI Biologics, Inc. sees FY2014 EPS of $0.07-$0.09, versus prior guidance of $0.06-$0.08 and... More
